Please login to the form below

Not currently logged in
Email:
Password:

albiglutide

This page shows the latest albiglutide news and features for those working in and with pharma, biotech and healthcare.

Sanofi's lixisenatide is back under FDA review

Sanofi's lixisenatide is back under FDA review

Meanwhile, new GLP-1 agonists that require dosing just once a week - including Eli Lilly's Trulicity (dulaglutide), GlaxoSmithKline's Tanzeum (albiglutide) AstraZeneca's Bydureon (exenatide) and Novo Nordisk's semaglutide -

Latest news

More from news
Approximately 4 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • Pharma deals during July 2012 Pharma deals during July 2012

    These are Benlysta (belimumab), an antibody approved for the treatment of lupus; darapladib, a phase III small molecule drug for the treatment of cardiovascular disease; and albiglutide, an albumin-fusion protein ... There is $150m in potential licence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...
Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...

Infographics